It is our pleasure to welcome you all to The European Conference on AI for Clinical Applications (Euraica2026) which will take place in Brussels, Belgium on 11 – 12 March, 2026.
This conference will explore how Artificial Intelligence (AI) is transforming the landscape of clinical research. From early protocol design to post-trial evidence generation, AI technologies are accelerating timelines, enhancing decision-making, and improving trial efficiency. By leveraging real-world data (RWD), predictive models, and automation tools, AI is driving a more adaptive, patient-centered, and evidence-driven R&D process. At the same time, these innovations raise new methodological, regulatory, and ethical questions that deserve collective attention.
We are proud to bring together leading voices from clinical research, AI technologies, and regulatory science to deliver both visionary and practical insights. The conference program will span a wide range of topics—from designing and running smarter trials with AI, to delivering meaningful, scalable evidence generation, and tackling emerging challenges at the intersection of innovation and regulation.
This event is a unique opportunity to engage with academic researchers, regulatory authorities, HTA representatives, investors, entrepreneurs, and executive leaders from pharmaceutical and biotech companies involved in clinical development, medical affairs, and regulatory strategy.
We also invite you to join us as a Sponsor or Exhibitor, and benefit from exceptional visibility and access to a forward-looking, cross-sector audience.
We look forward to welcoming you to Brussels for The European Conference on AI for Clinical Applications — and to shaping the future of clinical research together.
Sincerely,
